Torthaí cuardaigh - Brockbank J

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Íomhá chlúdaigh

    Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum] de réir Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J

    Foilsithe / Cruthaithe 2021
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Íomhá chlúdaigh

    Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain de réir Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J

    Foilsithe / Cruthaithe 2021
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: